UBS Group’s Adaptimmune Therapeutics ADAP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $15.1K | Sell |
62,958
-949,782
| -94% | -$228K | ﹤0.01% | 7312 |
|
|
2025
Q1 | $200K | Buy |
1,012,740
+870,996
| +614% | +$172K | ﹤0.01% | 5320 |
|
|
2024
Q4 | $76.4K | Buy |
141,744
+139,927
| +7,701% | +$75.4K | ﹤0.01% | 5823 |
|
|
2024
Q3 | $1.73K | Hold |
1,817
| – | – | ﹤0.01% | 7349 |
|
|
2024
Q2 | $1.77K | Sell |
1,817
-194,879
| -99% | -$190K | ﹤0.01% | 7331 |
|
|
2024
Q1 | $311K | Buy |
196,696
+172,003
| +697% | +$272K | ﹤0.01% | 4413 |
|
|
2023
Q4 | $19.6K | Sell |
24,693
-3,641
| -13% | -$2.89K | ﹤0.01% | 5911 |
|
|
2023
Q3 | $22.1K | Sell |
28,334
-2,646
| -9% | -$2.06K | ﹤0.01% | 5619 |
|
|
2023
Q2 | $28.7K | Buy |
30,980
+4,230
| +16% | +$3.91K | ﹤0.01% | 5664 |
|
|
2023
Q1 | $29.2K | Buy |
26,750
+3,125
| +13% | +$3.41K | ﹤0.01% | 5729 |
|
|
2022
Q4 | $34.5K | Buy |
23,625
+21,641
| +1,091% | +$31.6K | ﹤0.01% | 5933 |
|
|
2022
Q3 | $2K | Sell |
1,984
-2,720
| -58% | -$2.74K | ﹤0.01% | 8579 |
|
|
2022
Q2 | $8K | Sell |
4,704
-788
| -14% | -$1.34K | ﹤0.01% | 7236 |
|
|
2022
Q1 | $12K | Sell |
5,492
-11,080
| -67% | -$24.2K | ﹤0.01% | 7096 |
|
|
2021
Q4 | $61K | Buy |
16,572
+1,067
| +7% | +$3.93K | ﹤0.01% | 5643 |
|
|
2021
Q3 | $80K | Buy |
15,505
+1,593
| +11% | +$8.22K | ﹤0.01% | 4902 |
|
|
2021
Q2 | $60K | Sell |
13,912
-174,172
| -93% | -$751K | ﹤0.01% | 5208 |
|
|
2021
Q1 | $998K | Buy |
188,084
+6,502
| +4% | +$34.5K | ﹤0.01% | 3358 |
|
|
2020
Q4 | $978K | Buy |
181,582
+56,249
| +45% | +$303K | ﹤0.01% | 3180 |
|
|
2020
Q3 | $1M | Buy |
125,333
+125,263
| +178,947% | +$1M | ﹤0.01% | 2916 |
|
|
2020
Q2 | $1K | Sell |
70
-5,015
| -99% | -$71.6K | ﹤0.01% | 6868 |
|
|
2020
Q1 | $14K | Sell |
5,085
-1,142
| -18% | -$3.14K | ﹤0.01% | 5802 |
|
|
2019
Q4 | $7K | Buy |
6,227
+6,157
| +8,796% | +$6.92K | ﹤0.01% | 6353 |
|
|
2019
Q3 | $0 | Sell |
70
-8,030
| -99% | – | ﹤0.01% | 6974 |
|
|
2019
Q2 | $32K | Buy |
8,100
+2,630
| +48% | +$10.4K | ﹤0.01% | 5410 |
|
|
2019
Q1 | $24K | Sell |
5,470
-2,100
| -28% | -$9.21K | ﹤0.01% | 5310 |
|
|
2018
Q4 | $44K | Sell |
7,570
-110,258
| -94% | -$641K | ﹤0.01% | 5301 |
|
|
2018
Q3 | $1.6M | Buy |
117,828
+106,170
| +911% | +$1.44M | ﹤0.01% | 2774 |
|
|
2018
Q2 | $138K | Buy |
11,658
+8,228
| +240% | +$97.4K | ﹤0.01% | 4348 |
|
|
2018
Q1 | $38K | Sell |
3,430
-2,467
| -42% | -$27.3K | ﹤0.01% | 5056 |
|
|
2017
Q4 | $39K | Buy |
5,897
+4,397
| +293% | +$29.1K | ﹤0.01% | 5080 |
|
|
2017
Q3 | $12K | Sell |
1,500
-500
| -25% | -$4K | ﹤0.01% | 5853 |
|
|
2017
Q2 | $9K | Buy |
2,000
+1,228
| +159% | +$5.53K | ﹤0.01% | 5881 |
|
|
2017
Q1 | $4K | Sell |
772
-2
| -0.3% | -$10 | ﹤0.01% | 6122 |
|
|
2016
Q4 | $3K | Sell |
774
-2,436
| -76% | -$9.44K | ﹤0.01% | 6408 |
|
|
2016
Q3 | $23K | Buy |
+3,210
| New | +$23K | ﹤0.01% | 5292 |
|
|
2016
Q1 | – | Sell |
-5,164
| Closed | -$62K | – | 6677 |
|
|
2015
Q4 | $62K | Buy |
5,164
+3,303
| +177% | +$39.7K | ﹤0.01% | 4584 |
|
|
2015
Q3 | $22K | Sell |
1,861
-294
| -14% | -$3.48K | ﹤0.01% | 5369 |
|
|
2015
Q2 | $40K | Buy |
+2,155
| New | +$40K | ﹤0.01% | 4929 |
|